Ellen Vercalsteren

Articles

Article: CARDIOVASCULAR DIABETOLOGY. 2024;23(1):88

The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice

Vercalsteren E; Karampatsi D; Buizza C; Nyström T; Klein T; Paul G; Patrone C; Darsalia V
Article: DIABETES. 2023;72(3):405-414

DPP-4 Inhibitor and Sulfonylurea Differentially Reverse Type 2 Diabetes-Induced Blood-Brain Barrier Leakage and Normalize Capillary Pericyte Coverage.

Elabi OF; Karampatsi D; Vercalsteren E; Lietzau G; Nyström T; Klein T; Darsalia V; Patrone C; Paul G
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(4):3989

The Pre-Stroke Induction and Normalization of Insulin Resistance Respectively Worsens and Improves Functional Recovery.

Vercalsteren E; Karampatsi D; Dekens D; Letsiou A; Zabala A; Romanitan M; Klein T; Nyström T; Darsalia V; Patrone C
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022

The pre-stroke induction and normalization of insulin resistance respectively worsens and improves functional recovery

Vercalsteren E; Karampatsi D; Dekens D; Letsiou A; Zabala A; Romanitan M; Klein T; Nyström T; Darsalia V; Patrone C
Article: CARDIOVASCULAR DIABETOLOGY. 2021;20(1):240

Diet-induced weight loss in obese/diabetic mice normalizes glucose metabolism and promotes functional recovery after stroke.

Karampatsi D; Zabala A; Wilhelmsson U; Dekens D; Vercalsteren E; Larsson M; Nyström T; Pekny M; Patrone C; Darsalia V

Conference publication: EUROPEAN RESPIRATORY JOURNAL. 2023;62:pa664

Depression from childhood to early adulthood and association with respiratory symptoms

Wang G; Hallberg J; Vercalsteren E; Hernandez-Pacheco N; Ekstrom S; Brew BK; Almqvist C; Kull I; Bergstrom A; Melen E; Lu D